Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting

High lipoprotein(a) (Lp(a)) plasma levels are significantly associated with an increased risk of developing atherosclerotic cardiovascular diseases (ASCVD). The aim of this analysis was to estimate the prevalence and characteristics of patients potentially eligible for Lp(a)-lowering therapies in a...

詳細記述

書誌詳細

出版年:	Biomedicines
主要な著者:	Arrigo F. G. Cicero, Federica Fogacci, Marina Giovannini, Elisa Grandi, Sergio D’Addato, Claudio Borghi
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2023-12-01
主題:	lipoprotein(a) cardiovascular diseases ASCVD lipid clinic epidemiology
オンライン･アクセス:	https://www.mdpi.com/2227-9059/11/12/3289